Rosacea

White Wine and Liquor Consumption May Increase Risk of Rosacea

White wine consumption may increase risk of rosacea

New research published online on April 20, 2017 in the Journal of the American Academy of Dermatology revealed that increased consumption of alcohol, particularly white wine and liquor, is associated with a higher risk of rosacea in women.

To examine rosacea’s connection to alcohol use in women, the authors—led by Wen-Qing Li, an assistant professor of dermatology at Brown University—reviewed data collected from 82,737 women over 14 years (1991-2005) via the Nurses’ Health Study II. There were 4,945 cases on rosacea.

Rosacea Awareness Month: How To Take Part

April is Rosacea Awareness Month

April is Rosacea Awareness Month, and the National Rosacea Society (NRS) is encouraging physicians and patients to take part in educating the public on this chronic and widespread facial disorder now estimated to affect more than 16 million Americans.

The NRS designated April Rosacea Awareness Month 25 years ago in an effort to encourage more people who may have rosacea to seek medical help before it gets worse, and to help those affected find greater public acceptance and understanding.

Rosacea and Systemic Disease

New links between rosacea and systemic illnesses highlight the importance of medical histories and underscore the need for healthy skepticism.
Rosacea and Systemic Disease

In recent years, researchers have hypothesized that patients with rosacea may be at higher risk for systemic vascular concerns, such as coronary artery disease, as well as neurological disorders, including depression and anxiety. Most recently, a study in JAMA Neurology (May 2016), questioned whether the increased activity of matrix metalloproteinase (MMP) seen in patients with rosacea may offer a clue for the treatment of Parkinson’s Disease, setting up a tenuous connection between the two illnesses.

Foamix FMX103 Topical Minocycline Foam Improves Papulopustular Rosacea

Foamix Pharmaceuticals has announced the topline results of its Phase 2 clinical trial of FMX103 for the treatment of papulopustular rosacea. Statistically significant differences were demonstrated for improvement in the primary and secondary efficacy endpoints (reduction in the number of inflammatory lesions and improvement of Investigator Global Assessment (IGA) score) for FMX103 compared with the vehicle-treated group.

Calming Serum

Main Image: 
Calming Serum

Formulated for all skin types, RosaLieve Redness Reducing Complex from Jan Marini Skin Research features: azelaic acid, tetrapeptide-14 and ranunculus ficaria extract to minimize the severity and frequency of redness and flushing; oat, green tea, white tea and red tea extracts to reduce skin reactivity; and allantoin to calm irritated skin.

Contact: 888.695.2611, www.janmarini.com.

No, don't share this with BeautyEtc
Articles: 
Article free tagging: